Biography

1. Research Interest

Abdominal Surgery, Liver Cancer, Organ transplantation and perioperative management

2. Educational Background

1997/9-2000/7, doctor's degree in Oncology Surgery of Chinese Medical University

1991/9-1994/7, Master's Degree in Oncology Surgery, Chinese Medical University

1982/9-1987/7, Bachelor's Degree in Medical Department, Jinzhou Medical College

3.Work Experience

From September 2003 to now, director physician, Professor, Deputy Director, Director of Scientific Research, Director of Science and Education, Director of Medical Services and Vice-President in organ transplantation center of Tianjin First Central Hospital

2000/7-2003/9, assistant director physician/director physician in General Surgical Department, Tianjin First Central Hospital

1994/7-1997/9, head of General Surgical Department, Shuguang Hospital, Angang

1987/7-1991/9, house physician in General Surgical Department, Shuguang Hospital, Angang

4. Awards

The 3rd Prize of Chinese Medical Science Award, 2014 (201403288P0809)

The Second Prize for the State Scientific and Technological Progress Award(2010-T-253-2-06-ROS)

Third Prize of Science and Technology Award of China Anti-Cancer Association( K-0903-3-6-4)

5. Social Service

Chief committee member of Chinese Society of OrganTransplantation

chief committee member of Tianjin Organ Transplantation

deputy editor of Practical Journal of Organ Transplantation

Achievements

Peer-Reviewed Journal Papers

1. Wang Z,Teng D, Li Y,Hu Z,Liu L,Zheng H*. A six-gene-based prognostic signature for hepatocellular carcinoma overall survival prediction[J]. Life Sci, 2018, 203: 83-91.

2. Wang Z L,Zhang LZ,Wang Y L,Zheng W P,Zheng H*. Clinical Features and Clonal Origin of Diffuse Hepatocellular Carcinoma[J]. Chin Med J (Engl), 2018, 131(9): 1128-1131.

3.Gu X Q, Zheng H*, Teng D H, et al. Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients[J]. World J Gastroenterol, 2016, 22(9): 2749-2759.

4.Zheng H*,Wang Z, Shou D, et al. Clonal Origin of Hepatocellular Carcinoma and Recurrence After LiverTransplantation[J]. Ann Transplant, 2016, 21: 484-490.

5.Song ZL, Cui YJ, Zheng WP, Teng DH, Zheng H*. Application of nucleoside analogues to liver transplant recipients with hepatitis B. World J Gastroenterol. 2015 Nov 14;21(42):12091-100.

6. ZL S, YJ C, WP Z, Teng DH, Zheng H*.Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues[J]. Wor1d J Gastroenterol, 2012 Dec 28;18(48):7149-57.

Projects

National Natural Science Foundation(81170443, 81830060)

Program of internation S&T Cooperation(2015DFG31850)

National High-Tech R&D Program (863 Program) (No.2012AA021001,)

Tianjin Municipal Health ureau Key Project (No. 13KG103)